Literature DB >> 391696

Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

C A Brown, I N Brown, V S Sljivić.   

Abstract

Mycobacterium bovis, BCG, is known to be capable of either enhancing or suppressing various immune responses. Using a standard technique and number of organisms, some of the parameters predetermining whether enhancement or supression will occur have been investigated. Dead BCG given intravenously into mice caused an enhancement of the antibody response in vitro to sheep erythrocytes. In contrast, the same number of viable organisms caused suppression if given intravenously but enhancement if given subcutaneously. The inclusion of 25% or more killed organisms in an intravenous inoculum of fully viable organisms changed suppression to enhancement. Treatment of BCG infected mice with streptomycin lessened the suppression but did not change it to enhancement. The possible causes of suppression are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391696      PMCID: PMC1457820     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Active suppression of in vitro reactivity of spleen cells after BCG treatment.

Authors:  S Orbach-Arbouys; M F Poupon
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

2.  Research in leprosy. A report of a committee set up by the medical research council to study future prospects.

Authors: 
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

Review 3.  BCG in tumor immunotherapy.

Authors:  R W Baldwin; M V Pimm
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

4.  Antibody response in vitro of spleen cells from Plasmodium yoelii-infected mice.

Authors:  I N Brown; S R Watson; V S Sljivić
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG.

Authors:  M T Kelly
Journal:  Cell Immunol       Date:  1976-10       Impact factor: 4.868

6.  Immunodepression in Taenia crassiceps infection: restoration of the in vitro response to sheep erythrocytes by activated peritoneal cells.

Authors:  K L Miller; A H Good; R I Mishell
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Enhancement of the antibody response in vitro by BCG.

Authors:  C A Brown; I N Brown; V S Sljivíc
Journal:  Dev Biol Stand       Date:  1977 Apr 13-15

8.  Infection with Bacillus Calmette-Guérin activates murine thymus-independent (B) lymphocytes.

Authors:  B M Sultzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

9.  Opposite effects of BCG on spleen and lymph node cells: lymphocyte proliferation and immunoglobulin synthesis.

Authors:  R Turcotte; L Lafleur; M Labrèche
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

10.  Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition.

Authors:  I A Clark; E J Wills; J E Richmond; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

View more
  9 in total

1.  Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.

Authors:  R Turcotte; D Legault
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes.

Authors:  J M Douglas; L A Vontver; W E Stamm; W C Reeves; C Critchlow; M L Remington; K K Holmes; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

3.  Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

4.  Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms.

Authors:  C A Brown; I N Brown
Journal:  Br J Exp Pathol       Date:  1982-04

5.  Effect of chemotherapy on suppressor T cells in BCG-infected mice.

Authors:  F M Collins; S R Watson
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

6.  BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

7.  Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice.

Authors:  E J Wing
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

8.  Cutaneous unresponsiveness to Mycobacterium bovis BCG in intravenously infected mice.

Authors:  R Turcotte; A Forget
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice.

Authors:  R Turcotte
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.